Recombinant Vaccines Market Size, Share, Growth, and Industry Analysis, By Types (Subunit Recombinant Vaccines, Attenuated Recombinant Vaccines, Vector Recombinant Vaccines) , Applications (Recombinant Human Vaccines, Animal Recombinant Vaccines) and Regional Insights and Forecast to 2033

Detailed TOC of Global Recombinant Vaccines Market Research Report 2025

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Vaccines Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Subunit Recombinant Vaccines
1.2.3 Attenuated Recombinant Vaccines
1.2.4 Vector Recombinant Vaccines
1.3 Market by Application
1.3.1 Global Recombinant Vaccines Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Recombinant Human Vaccines
1.3.3 Animal Recombinant Vaccines
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Vaccines Market Perspective (2018-2033)
2.2 Recombinant Vaccines Growth Trends by Region
2.2.1 Global Recombinant Vaccines Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Recombinant Vaccines Historic Market Size by Region (2018-2025)
2.2.3 Recombinant Vaccines Forecasted Market Size by Region (2024-2033)
2.3 Recombinant Vaccines Market Dynamics
2.3.1 Recombinant Vaccines Industry Trends
2.3.2 Recombinant Vaccines Market Drivers
2.3.3 Recombinant Vaccines Market Challenges
2.3.4 Recombinant Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Vaccines Players by Revenue
3.1.1 Global Top Recombinant Vaccines Players by Revenue (2018-2025)
3.1.2 Global Recombinant Vaccines Revenue Market Share by Players (2018-2025)
3.2 Global Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Vaccines Revenue
3.4 Global Recombinant Vaccines Market Concentration Ratio
3.4.1 Global Recombinant Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Vaccines Revenue in 2022
3.5 Recombinant Vaccines Key Players Head office and Area Served
3.6 Key Players Recombinant Vaccines Product Solution and Service
3.7 Date of Enter into Recombinant Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Vaccines Breakdown Data by Type
4.1 Global Recombinant Vaccines Historic Market Size by Type (2018-2025)
4.2 Global Recombinant Vaccines Forecasted Market Size by Type (2024-2033)
5 Recombinant Vaccines Breakdown Data by Application
5.1 Global Recombinant Vaccines Historic Market Size by Application (2018-2025)
5.2 Global Recombinant Vaccines Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Recombinant Vaccines Market Size (2018-2033)
6.2 North America Recombinant Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Recombinant Vaccines Market Size by Country (2018-2025)
6.4 North America Recombinant Vaccines Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Vaccines Market Size (2018-2033)
7.2 Europe Recombinant Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Recombinant Vaccines Market Size by Country (2018-2025)
7.4 Europe Recombinant Vaccines Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Vaccines Market Size (2018-2033)
8.2 Asia-Pacific Recombinant Vaccines Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Recombinant Vaccines Market Size by Region (2018-2025)
8.4 Asia-Pacific Recombinant Vaccines Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Vaccines Market Size (2018-2033)
9.2 Latin America Recombinant Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Recombinant Vaccines Market Size by Country (2018-2025)
9.4 Latin America Recombinant Vaccines Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Vaccines Market Size (2018-2033)
10.2 Middle East & Africa Recombinant Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Recombinant Vaccines Market Size by Country (2018-2025)
10.4 Middle East & Africa Recombinant Vaccines Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co., Inc
11.1.1 Merck & Co., Inc Company Detail
11.1.2 Merck & Co., Inc Business Overview
11.1.3 Merck & Co., Inc Recombinant Vaccines Introduction
11.1.4 Merck & Co., Inc Revenue in Recombinant Vaccines Business (2018-2025)
11.1.5 Merck & Co., Inc Recent Development
11.2 Green Cross Corporation
11.2.1 Green Cross Corporation Company Detail
11.2.2 Green Cross Corporation Business Overview
11.2.3 Green Cross Corporation Recombinant Vaccines Introduction
11.2.4 Green Cross Corporation Revenue in Recombinant Vaccines Business (2018-2025)
11.2.5 Green Cross Corporation Recent Development
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Detail
11.3.2 Pfizer Inc. Business Overview
11.3.3 Pfizer Inc. Recombinant Vaccines Introduction
11.3.4 Pfizer Inc. Revenue in Recombinant Vaccines Business (2018-2025)
11.3.5 Pfizer Inc. Recent Development
11.4 Bayer AG
11.4.1 Bayer AG Company Detail
11.4.2 Bayer AG Business Overview
11.4.3 Bayer AG Recombinant Vaccines Introduction
11.4.4 Bayer AG Revenue in Recombinant Vaccines Business (2018-2025)
11.4.5 Bayer AG Recent Development
11.5 Sanofi S A.
11.5.1 Sanofi S A. Company Detail
11.5.2 Sanofi S A. Business Overview
11.5.3 Sanofi S A. Recombinant Vaccines Introduction
11.5.4 Sanofi S A. Revenue in Recombinant Vaccines Business (2018-2025)
11.5.5 Sanofi S A. Recent Development
11.6 Protein Science Corporation
11.6.1 Protein Science Corporation Company Detail
11.6.2 Protein Science Corporation Business Overview
11.6.3 Protein Science Corporation Recombinant Vaccines Introduction
11.6.4 Protein Science Corporation Revenue in Recombinant Vaccines Business (2018-2025)
11.6.5 Protein Science Corporation Recent Development
11.7 GlaxoSmithKline Plc.
11.7.1 GlaxoSmithKline Plc. Company Detail
11.7.2 GlaxoSmithKline Plc. Business Overview
11.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Introduction
11.7.4 GlaxoSmithKline Plc. Revenue in Recombinant Vaccines Business (2018-2025)
11.7.5 GlaxoSmithKline Plc. Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Detail
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Recombinant Vaccines Introduction
11.8.4 Novartis AG Revenue in Recombinant Vaccines Business (2018-2025)
11.8.5 Novartis AG Recent Development
11.9 Bharat Biotech
11.9.1 Bharat Biotech Company Detail
11.9.2 Bharat Biotech Business Overview
11.9.3 Bharat Biotech Recombinant Vaccines Introduction
11.9.4 Bharat Biotech Revenue in Recombinant Vaccines Business (2018-2025)
11.9.5 Bharat Biotech Recent Development
11.10 AstraZeneca Plc.
11.10.1 AstraZeneca Plc. Company Detail
11.10.2 AstraZeneca Plc. Business Overview
11.10.3 AstraZeneca Plc. Recombinant Vaccines Introduction
11.10.4 AstraZeneca Plc. Revenue in Recombinant Vaccines Business (2018-2025)
11.10.5 AstraZeneca Plc. Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Recombinant Vaccines Introduction
11.11.4 Johnson & Johnson Revenue in Recombinant Vaccines Business (2018-2025)
11.11.5 Johnson & Johnson Recent Development
11.12 Emergent BioSolutions Inc
11.12.1 Emergent BioSolutions Inc Company Detail
11.12.2 Emergent BioSolutions Inc Business Overview
11.12.3 Emergent BioSolutions Inc Recombinant Vaccines Introduction
11.12.4 Emergent BioSolutions Inc Revenue in Recombinant Vaccines Business (2018-2025)
11.12.5 Emergent BioSolutions Inc Recent Development
11.13 Novavax, Inc
11.13.1 Novavax, Inc Company Detail
11.13.2 Novavax, Inc Business Overview
11.13.3 Novavax, Inc Recombinant Vaccines Introduction
11.13.4 Novavax, Inc Revenue in Recombinant Vaccines Business (2018-2025)
11.13.5 Novavax, Inc Recent Development
11.14 Serum Institute of India Pvt. Ltd
11.14.1 Serum Institute of India Pvt. Ltd Company Detail
11.14.2 Serum Institute of India Pvt. Ltd Business Overview
11.14.3 Serum Institute of India Pvt. Ltd Recombinant Vaccines Introduction
11.14.4 Serum Institute of India Pvt. Ltd Revenue in Recombinant Vaccines Business (2018-2025)
11.14.5 Serum Institute of India Pvt. Ltd Recent Development
11.15 Dynavax Technologies Corporation
11.15.1 Dynavax Technologies Corporation Company Detail
11.15.2 Dynavax Technologies Corporation Business Overview
11.15.3 Dynavax Technologies Corporation Recombinant Vaccines Introduction
11.15.4 Dynavax Technologies Corporation Revenue in Recombinant Vaccines Business (2018-2025)
11.15.5 Dynavax Technologies Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details